When FDA Changes Your Payment Plans

Five sponsors withdrew their applications for new technology add-on payments from CMS – all due to regulatory reasons happening at the US FDA.

Regulatory shifts at FDA can abruptly shift the reimbursement climate at CMS. • Source: Alamy

Timing regulatory strategies with reimbursement has never been more important—particularly for complex therapies that require inpatient services and management.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Medicare

More from Government Payers